Company Filing History:
Years Active: 2007-2010
Title: Noël Tordo: Innovator in Immunogenic Research
Introduction
Noël Tordo is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunogenic research, particularly in the development of chimeric nucleic acids and polypeptides. With a total of three patents to his name, Tordo's work has the potential to enhance vaccine efficacy and broaden the scope of immunological protection.
Latest Patents
Tordo's latest patents focus on chimeric lyssavirus nucleic acids and polypeptides. These inventions provide chimeric nucleic acids, preferably contained on an expression vector, that encode chimeric immunogenic polypeptides. The nucleic acids encode at least site III of a lyssavirus glycoprotein, which has been found to improve the immunogenicity of lyssavirus epitopes for protection from rabies. The chimeric nucleic acids and proteins can also contain antigenic determinants for epitopes other than those of lyssavirus. Thus, the invention provides chimeric nucleic acids and polypeptides that elicit a strong immune response to multiple antigens. The methods of the present invention permit DNA vaccination without the need to supply multiple antigens on separate DNA molecules.
Career Highlights
Noël Tordo is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to microbiology and immunology. His work at this prestigious institute has allowed him to explore innovative solutions to pressing health challenges. Tordo's research has been instrumental in advancing our understanding of viral immunology and vaccine development.
Collaborations
Tordo has collaborated with notable colleagues in his field, including Yves Jacob and Pierre Perrin. These collaborations have fostered a rich exchange of ideas and have contributed to the advancement of research in immunogenicity.
Conclusion
Noël Tordo's innovative work in the field of immunogenic research exemplifies the impact of scientific inquiry on public health. His patents and collaborations continue to pave the way for advancements in vaccine technology and disease prevention.